LRIG1 and central nervous system cancer: This inhibitory effect is achieved through the upregulation of LRIG1 gene expression, showcasing LRIG1 as a pivotal factor in the anti-glioma properties of resveratrol, which unveils LRIG1 as a novel biological target of resveratrol in the context of antagonizing cell proliferation and growth in glioma cells [19].